Post-COVID and diabetes mellitus

Bandelin-Franke, Lena; Scheibenbogen, Carmen; Bobbert, Thomas

doi:10.1007/s11428-024-01157-1

Diabetologie

2024

DOI: 10.1007/s11428-024-01157-1

|View full text |Cite

Post-COVID and diabetes mellitus

Lena Bandelin-Franke,

Carmen Scheibenbogen,

Thomas Bobbert

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways

Maiese

2024

World J Cardiol

View full text Add to dashboard Cite

As a non-communicable disease, cardiovascular disorders have become the leading cause of death for men and women. Of additional concern is that cardiovascular disease is linked to chronic comorbidity disorders that include nonalcoholic fatty liver disease (NAFLD). NAFLD, also termed metabolic-dysfunction-associated steatotic liver disease, is the greatest cause of liver disease throughout the world, increasing in prevalence concurrently with diabetes mellitus (DM), and can progress to nonalcoholic steatohepatitis that leads to cirrhosis and liver fibrosis. Individuals with metabolic disorders, such as DM, are more than two times likely to experience cardiac disease, stroke, and liver disease that includes NAFLD when compared individuals without metabolic disorders. Interestingly, cardiovascular disorders and NAFLD share a common underlying cellular mechanism for disease pathology, namely the silent mating type information regulation 2 homolog 1 (SIRT1; Saccharomyces cerevisiae ). SIRT1, a histone deacetylase, is linked to metabolic pathways through nicotinamide adenine dinucleotide and can offer cellular protection though multiple avenues, including trophic factors such as erythropoietin, stem cells, and AMP-activated protein kinase. Translating SIRT1 pathways into clinical care for cardiovascular and hepatic disease can offer significant hope for patients, but further insights into the complexity of SIRT1 pathways are necessary for effective treatment regimens.

show abstract

Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways

Maiese

2024

World J Cardiol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Post-COVID and diabetes mellitus

Cited by 1 publication

References 50 publications

Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways

Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways

Contact Info

Product

Resources

About